PURE Bioscience Schedules First Quarter 2010 Financial Results Conference Call for December 11, 2009 at 1:30 P.M. PST

San Diego, Calif. – December 4,2009 – PURE Bioscience (NASDAQ: PURE) today announced that Michael L. Krall, President and CEO, will host a conference call on Friday, December 11, 2009 at 1:30 P.M. PST to review and discuss first quarter 2010 financial results. 

Shareholders and other interested parties may participate in the conference call by dialing 877-407-8033 or (International) 201 689-8033 a few minutes before 1:30 P.M. PST on December 11, 2009.

The call is being webcast by Vcall and can be accessed at www.purebio.com. Investors can also access the webcast at www.InvestorCalendar.com 

The webcast will be available for replay through March 10, 2010.  A replay of the conference call will be accessible until February 10, 2010 by dialing 877-660-6853 or (International) 201-612-7415and entering the Account#: 286 and the Conference ID#: 338668. 

About PURE Bioscience

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges.  PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate (SDC)- based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety.  Patented SDC is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds.  As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it.  PURE is headquartered in El Cajon, California (San Diego metropolitan area).  Additional information on PURE is available at www.purebio.com.